BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36844708)

  • 21. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
    Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
    Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospital.
    Mironova M; Ehrlich AC; Grinspan A; Protano MA
    J Dig Dis; 2022 Aug; 23(8-9):500-505. PubMed ID: 36183340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridioides
    Gawey BJ; Khanna S
    Gastroenterol Hepatol (N Y); 2023 Jun; 19(6):319-328. PubMed ID: 37706187
    [No Abstract]   [Full Text] [Related]  

  • 24. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.
    Fischer M; Sipe B; Cheng YW; Phelps E; Rogers N; Sagi S; Bohm M; Xu H; Kassam Z
    Gut Microbes; 2017 May; 8(3):289-302. PubMed ID: 28001467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world effectiveness of fecal microbiota transplantation for first or second Clostridioides difficile infection.
    Paaske SE; Dahl Baumwall SM; Rubak T; Birn FH; Rågård N; Kelsen J; Hansen MM; Svenningsen L; Krarup AL; Culmbach Fernis CM; Neumann A; Lødrup AB; Glerup H; Vinter-Jensen L; Helms M; Erikstrup LT; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
    Clin Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38871148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital.
    Duarte-Chavez R; Wojda TR; Zanders TB; Geme B; Fioravanti G; Stawicki SP
    J Glob Infect Dis; 2018; 10(2):47-57. PubMed ID: 29910564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent
    van Lingen EE; Baunwall SSMD; Lieberknecht SSC; Benech NN; Ianiro GG; Sokol HH; Gasbarrini AA; Cammarota GG; Eriksen MMK; van der Meulen-de Jong AAE; Terveer EEM; Verspaget HHW; Vehreschild MM; Hvas CCL; Keller JJJ
    Therap Adv Gastroenterol; 2023; 16():17562848231156285. PubMed ID: 36910163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent
    Stallhofer J; Steube A; Katzer K; Stallmach A
    Visc Med; 2024 Apr; 40(2):82-91. PubMed ID: 38584858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome.
    Gotoh K; Sakaguchi Y; Kato H; Osaki H; Jodai Y; Wakuda M; Také A; Hayashi S; Morita E; Sugie T; Ito Y; Ohmiya N
    Anaerobe; 2022 Feb; 73():102502. PubMed ID: 34896553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
    Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent
    Wang Y; Hunt A; Danziger L; Drwiega EN
    Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786164
    [No Abstract]   [Full Text] [Related]  

  • 34. Fecal Microbiota Transplantation as Emerging Treatment in European Countries 2.0.
    Porcari S; Maida M; Bibbò S; McIlroy J; Ianiro G; Cammarota G
    Adv Exp Med Biol; 2024; 1435():85-99. PubMed ID: 38175472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
    Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M
    Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile Infection.
    Aby ES; Vaughn BP; Enns EA; Rajasingham R
    Clin Infect Dis; 2022 Oct; 75(9):1602-1609. PubMed ID: 35275989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current challenges in the treatment of severe
    van Beurden YH; Nieuwdorp M; van de Berg PJEJ; Mulder CJJ; Goorhuis A
    Therap Adv Gastroenterol; 2017 Apr; 10(4):373-381. PubMed ID: 28491142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.
    Fischer M; Sipe BW; Rogers NA; Cook GK; Robb BW; Vuppalanchi R; Rex DK
    Aliment Pharmacol Ther; 2015 Aug; 42(4):470-6. PubMed ID: 26096320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
    Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
    J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of fecal microbiota transplant in 9 critically ill patients with severe and complicated Clostridium difficile infection with impending colectomy.
    Alukal J; Dutta SK; Surapaneni BK; Le M; Tabbaa O; Phillips L; Mattar MC
    J Dig Dis; 2019 Jun; 20(6):301-307. PubMed ID: 30969003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.